XML 56 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Schedule of Common Stock Outstanding (Details) - shares
 12 Months Ended
Oct. 11, 2024
Oct. 09, 2024
Jun. 24, 2024
Sep. 22, 2023
Aug. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Business Acquisition [Line Items]              
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares 11,380            
Total - Conduit Pharmaceuticals Inc. common stock outstanding as a result of Business Combination, PIPE Financing, exchange of Conduit Pharmaceuticals Limited shares for shares of Conduit Pharmaceuticals Inc., issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes, and transaction services agreements, shares           1,384,801 738,295
Common Stock [Member]              
Business Acquisition [Line Items]              
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares   20,000 961   65,000,000 125,000  
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the transaction, shares           19,500  
Murphy Canyon Acquisition Corp [Member]              
Business Acquisition [Line Items]              
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares       540      
Total - Conduit Pharmaceuticals Inc. common stock outstanding as a result of Business Combination, PIPE Financing, exchange of Conduit Pharmaceuticals Limited shares for shares of Conduit Pharmaceuticals Inc., issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes, and transaction services agreements, shares       724,181      
Murphy Canyon Acquisition Corp [Member] | Subscription Agreements [Member]              
Business Acquisition [Line Items]              
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares       20,000      
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member]              
Business Acquisition [Line Items]              
Business Combination, net of redemptions, shares       41,182      
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares       3,735      
Exchange of Conduit Pharmaceuticals Limited ordinary shares for Conduit Pharmaceuticals Inc. common stock on the Closing Date, shares       646,264      
Issuance of Conduit Pharmaceuticals Inc. common stock to an advisor for services directly related to the transaction, shares       13,000      
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Subscription Agreements [Member]              
Business Acquisition [Line Items]              
Issuance of Conduit Pharmaceuticals Inc. common stock to holders of Conduit Pharmaceuticals Limited convertible notes on the Closing Date,shares       20,000      
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Sponsor [Member]              
Business Acquisition [Line Items]              
Business Combination, net of redemptions, shares       40,152      
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Director [Member]              
Business Acquisition [Line Items]              
Business Combination, net of redemptions, shares       450      
Murphy Canyon Acquisition Corp [Member] | Common Stock [Member] | Common Stock Subject to Mandatory Redemption [Member]              
Business Acquisition [Line Items]              
Business Combination, net of redemptions, shares       580